Literature DB >> 4844103

Nucleus ruber and L-dopa psychosis: biochemical post-mortem findings.

W Birkmayer, W Danielczyk, E Neumayer, P Riederer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4844103     DOI： 10.1007/bf01250738

Source DB:  PubMed          Journal:  J Neural Transm            Impact factor:   3.575


× No keyword cloud information.
  30 in total

1.  Differential extractions for the spectrophotofluorometric measurement of diverse 5-hydroxy- and 5-methoxyindoles.

Authors:  W B QUAY
Journal:  Anal Biochem       Date:  1963-01       Impact factor: 3.365

2.  A fluorometric procedure for the measurement of tryptamine in tissues.

Authors:  S M HESS; S UDENFRIEND
Journal:  J Pharmacol Exp Ther       Date:  1959-11       Impact factor: 4.030

3.  L-dopa: effect on concentrations of dopamine, norepinephrine, and serotonin in brains of mice.

Authors:  G M Everett; J W Borcherding
Journal:  Science       Date:  1970-05-15       Impact factor: 47.728

4.  [Experimental findings and new aspects in extrapyramidal diseases].

Authors:  W Birkmayer
Journal:  Wien Z Nervenheilkd Grenzgeb       Date:  1966

5.  [2-year experiences with a combination treatment of Parkinsonism with L-dopa and a decarboxylase inhibitor (Benserazid, Ro 4-4602)].

Authors:  W Birkmayer; W Linauer; M Mentasti; P Riederer
Journal:  Wien Med Wochenschr       Date:  1974-06-01

6.  Behavioral and biochemical effects of L-dopa after peripheral decarboxylase inhibition.

Authors:  L L Butcher; J Engel
Journal:  Brain Res       Date:  1969-09       Impact factor: 3.252

7.  Parkinsonism: onset, progression and mortality.

Authors:  M M Hoehn; M D Yahr
Journal:  Neurology       Date:  1967-05       Impact factor: 9.910

8.  Drug-induced changes in the concentration of 5-OR indolyl compounds in cerebrospinal fluid and caudate nucleus.

Authors:  G W ASHCROFT; D F SHARMAN
Journal:  Br J Pharmacol Chemother       Date:  1962-08

9.  L-tryptophan in the treatment of levodopa induced psychiatric disorders.

Authors:  E M Miller; H A Nieburg
Journal:  Dis Nerv Syst       Date:  1974-01

10.  L-Dopa-induced release of cerebral monoamines.

Authors:  K Y Ng; T N Chase; R W Colburn; I J Kopin
Journal:  Science       Date:  1970-10-02       Impact factor: 47.728
View more
  16 in total

Review 1.  An update expert opinion on management and research strategies in Parkinson's disease psychosis.

Authors:  Jennifer G Goldman; Christina L Vaughan; Christopher G Goetz
Journal:  Expert Opin Pharmacother       Date:  2011-06-02       Impact factor: 3.889

2.  L-Tryptophan: Biochemical, nutritional and pharmacological aspects.

Authors:  E L Sainio; K Pulkki; S N Young
Journal:  Amino Acids       Date:  1996-03       Impact factor: 3.520

3.  Brain-noradrenaline and 3-methoxy-4-hydroxyphenylglycol in Parkinson's syndrome.

Authors:  P Riederer; W Birkmayer; D Seemann; S Wuketich
Journal:  J Neural Transm       Date:  1977       Impact factor: 3.575

4.  Effect of hypoglycaemia, TRH and levodopa on plasma growth hormone, prolactin, thyrotropin and cortisol in Parkinson's disease before and during therapy.

Authors:  H P Vogel; R Ketsche
Journal:  J Neurol       Date:  1986-06       Impact factor: 4.849

5.  Endogenous ligands of a putative LSD-serotonin receptor in the cerebrospinal fluid: higher level of LSD-displacing factors (LDF) in unmedicated psychotic patients.

Authors:  E Mehl; E Rüther; J Redemann
Journal:  Psychopharmacology (Berl)       Date:  1977-08-31       Impact factor: 4.530

6.  Brain monoamines in human hepatic encephalopathy.

Authors:  K Jellinger; P Riederer; G Kleinberger; S Wuketich; P Kothbauer
Journal:  Acta Neuropathol       Date:  1978-08-07       Impact factor: 17.088

7.  Brain monoamines in metabolic (endotoxic) coma. A preliminary biochemical study in human postmortem material.

Authors:  K Jellinger; P Riederer
Journal:  J Neural Transm       Date:  1977       Impact factor: 3.575

8.  Transitional states of central serotonin receptors in Parkinson's disease.

Authors:  E Kienzl; P Riederer; K Jellinger; W Wesemann
Journal:  J Neural Transm       Date:  1981       Impact factor: 3.575

9.  Plasma profiles of adrenocorticotropic hormone, cortisol, growth hormone and prolactin in patients with untreated Parkinson's disease.

Authors:  G Bellomo; L Santambrogio; M Fiacconi; A M Scarponi; G Ciuffetti
Journal:  J Neurol       Date:  1991-02       Impact factor: 4.849

Review 10.  Post-mortem distribution of dopamine and homovanillic acid in human brain, variations related to age, and a review of the literature.

Authors:  R Adolfsson; C G Gottfries; B E Roos; B Winblad
Journal:  J Neural Transm       Date:  1979       Impact factor: 3.575
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.